» Authors » Javier de Juan Baguda

Javier de Juan Baguda

Explore the profile of Javier de Juan Baguda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 33
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Cordero Pereda D, de Rueda Panadero C, de Juan Baguda J, Gomez Bueno M, Robles-Mezcua A, Alvarez-Garcia J
Rev Esp Cardiol (Engl Ed) . 2023 Nov; 77(4):342-344. PMID: 37981190
No abstract available.
12.
Gonzalez-Costello J, Perez-Blanco A, Delgado-Jimenez J, Gonzalez-Vilchez F, Mirabet S, Sandoval E, et al.
Rev Esp Cardiol (Engl Ed) . 2023 Nov; 77(1):69-78. PMID: 37926340
Heart transplant (HT) remains the best therapeutic option for patients with advanced heart failure (HF). The allocation criteria aim to guarantee equitable access to HT and prioritize patients with a...
13.
Rodriguez Munoz D, Crespo-Leiro M, Fernandez Lozano I, Zamorano Gomez J, Peinado Peinado R, Manzano Espinosa L, et al.
ESC Heart Fail . 2023 Sep; 10(6):3700-3709. PMID: 37731197
Aims: Atrial fibrillation (AF) worsens the prognosis of patients with heart failure (HF). Successful treatments are still very scarce for those with permanent AF and preserved (HFpEF) or mildly reduced...
14.
de Juan Baguda J, de Frutos F, Lopez-Vilella R, Couto Mallon D, Guzman-Bofarull J, Blazquez-Bermejo Z, et al.
Rev Esp Cardiol (Engl Ed) . 2023 Jul; 77(4):290-301. PMID: 37516313
Introduction And Objectives: Repetitive ambulatory doses of levosimendan are an option as a bridge to heart transplantation (HT), but evidence regarding the safety and efficacy of this treatment is scarce....
15.
Esteban-Fernandez A, Gomez-Otero I, Lopez-Fernandez S, Rodriguez Santamarta M, Pastor-Perez F, Fluvia-Brugues P, et al.
Clin Res Cardiol . 2023 Jun; 113(8):1171-1182. PMID: 37341769
Aims: Heart failure (HF) guidelines recommend treating all patients with HF and reduced ejection fraction (HFrEF) with quadruple therapy, although they do not establish how to start it. This study...
16.
de Juan Baguda J, Rodriguez Chaverri A, Caravaca Perez P, Aguilar-Rodriguez F, Garcia-Cosio Carmena M, Mirabet Perez S, et al.
Rev Esp Cardiol (Engl Ed) . 2023 May; 76(11):852-861. PMID: 37182724
Introduction And Objectives: Hypertension is highly common in heart failure (HF). However, there is limited information on its prevalence, circadian variation, and relationship with the various HF phenotypes. The objective...
17.
Alvarez-Garcia J, Cristo Ropero M, Iniesta Manjavacas A, Diez-Villanueva P, Esteban-Fernandez A, de Juan Baguda J, et al.
Curr Heart Fail Rep . 2023 Apr; 20(3):151-156. PMID: 37022560
Purpose Of Review: Our aim was to assess the degree of acceptance of the European Clinical Practice Guidelines (CPG) on heart failure (HF) among Spanish physicians according to sex. This...
18.
Acena A, de Juan Baguda J, Rincon L
J Clin Med . 2022 Aug; 11(16). PMID: 36013089
Heart failure (HF) is a complex clinical syndrome that results from the structural and/or functional impairment of systolic function or ventricular filling, which in turn causes elevated intracardiac pressure and/or...
19.
Lopez-Azor J, De la Torre N, Garcia-Cosio Carmena M, Caravaca Perez P, Munera C, MarcoClement I, et al.
Card Fail Rev . 2022 May; 8:e13. PMID: 35516795
Telemonitoring through multiple variables measured on cardiac devices has the potential to improve the follow-up of patients with heart failure. The HeartLogic algorithm (Boston Scientific), implemented in some implantable cardiac...
20.
de Juan Baguda J, Gavira Gomez J, Pachon Iglesias M, Cozar Leon R, Escolar Perez V, Gonzalez Fernandez O, et al.
Rev Esp Cardiol (Engl Ed) . 2021 Dec; 75(9):709-716. PMID: 34896031
Introduction And Objectives: HeartLogic is a multiparametric algorithm incorporated into implantable cardioverter-defibrillators (ICD). The associated alerts predict impending heart failure (HF) decompensations. Our objective was to analyze the association between...